Recently, a novel anti-obesity mechanism of SGLT2 inhibition was reported, where EMPA treatment decreased adipose macrophage infiltration and increased energy expenditure in a model of diet-induced obesity [41]. The gene discussed is SLC5A2; the disease is Obesity.